BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19196660)

  • 21. Numerical gain and structural rearrangements of JAK2, identified by FISH, characterize both JAK2617V>F-positive and -negative patients with Ph-negative MPD, myelodysplasia, and B-lymphoid neoplasms.
    Najfeld V; Cozza A; Berkofsy-Fessler W; Prchal J; Scalise A
    Exp Hematol; 2007 Nov; 35(11):1668-76. PubMed ID: 17976519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct development of functionally mature tryptase/chymase double-positive connective tissue-type mast cells from primate embryonic stem cells.
    Ma F; Kambe N; Wang D; Shinoda G; Fujino H; Umeda K; Fujisawa A; Ma L; Suemori H; Nakatsuji N; Miyachi Y; Torii R; Tsuji K; Heike T; Nakahata T
    Stem Cells; 2008 Mar; 26(3):706-14. PubMed ID: 17991916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mast cell involvement in normal human skin wound healing: expression of monocyte chemoattractant protein-1 is correlated with recruitment of mast cells which synthesize interleukin-4 in vivo.
    Trautmann A; Toksoy A; Engelhardt E; Bröcker EB; Gillitzer R
    J Pathol; 2000 Jan; 190(1):100-6. PubMed ID: 10640999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of interleukin 3, interleukin 4, and fibroblasts on cultures of human lung mast cells in bronchoalveolar lavage fluids.
    Tanno Y; Shindoh Y; Takishima T
    Cell Struct Funct; 1990 Jun; 15(3):137-42. PubMed ID: 2397501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mast cells in abdominal aortic aneurysms.
    Shi GP; Lindholt JS
    Curr Vasc Pharmacol; 2013 May; 11(3):314-26. PubMed ID: 22724485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased neutrophil respiratory burst in myeloproliferative disorders: selective enhancement of superoxide release triggered by receptor-mediated agonists and low responsiveness to in vitro cytokine stimulation.
    Iki S; Yuo A; Yagisawa M; Inuo EK; Inoue Y; Usuki K; Urabe A; Suzuki K; Kitagawa S; Togawa A; Takaku F
    Exp Hematol; 1997 Jan; 25(1):26-33. PubMed ID: 8989903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adipocytokines leptin and adiponectin function as mast cell activity modulators.
    Żelechowska P; Brzezińska-Błaszczyk E; Wiktorska M; Różalska S; Wawrocki S; Kozłowska E; Agier J
    Immunology; 2019 Sep; 158(1):3-18. PubMed ID: 31220342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human induced pluripotent stem cell-derived mast cells useful for in vitro mast cell activation assay exhibiting phenotypes and morphological characteristics of human mast cells.
    Ikuno T; Ito S; Inoue T
    J Toxicol Sci; 2019; 44(11):789-797. PubMed ID: 31708535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel method to generate and culture human mast cells: Peripheral CD34+ stem cell-derived mast cells (PSCMCs).
    Schmetzer O; Valentin P; Smorodchenko A; Domenis R; Gri G; Siebenhaar F; Metz M; Maurer M
    J Immunol Methods; 2014 Nov; 413():62-8. PubMed ID: 25038510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Mast Cell Is an Early Activator of Lipopolysaccharide-Induced Neuroinflammation and Blood-Brain Barrier Dysfunction in the Hippocampus.
    Wang Y; Sha H; Zhou L; Chen Y; Zhou Q; Dong H; Qian Y
    Mediators Inflamm; 2020; 2020():8098439. PubMed ID: 32184702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of mast cell subtypes, distribution, and antigen-induced activation in the guinea pig esophagus.
    Yu S; Li Q; Cavanaugh S; Undem BJ; Ouyang A
    Dis Esophagus; 2009; 22(7):600-5. PubMed ID: 19222531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mast cells generated from patients with atopic eczema have enhanced levels of granule mediators and an impaired Dectin-1 expression.
    Ribbing C; Engblom C; Lappalainen J; Lindstedt K; Kovanen PT; Karlsson MA; Lundeberg L; Johansson C; Nilsson G; Lunderius-Andersson C; Scheynius A
    Allergy; 2011 Jan; 66(1):110-9. PubMed ID: 20608913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of interleukin-4 with or without mast cell growth factor on peripheral blood granulocyte-macrophage colony-forming cells in healthy controls and in myeloproliferative disorders.
    Siitonen T; Zheng A; Savolainen ER; Koistinen P
    Ann Hematol; 1995 Apr; 70(4):203-7. PubMed ID: 7538328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The release of tryptase from mast cells promote tumor cell metastasis via exosomes.
    Xiao H; He M; Xie G; Liu Y; Zhao Y; Ye X; Li X; Zhang M
    BMC Cancer; 2019 Oct; 19(1):1015. PubMed ID: 31664930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [An in vitro study on substance P-stimulated neuro-immune mechanism of mast cell degranulation].
    Li Q; Zhao C
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jun; 29(12):1118-20. PubMed ID: 26514006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin-3.
    Kobayashi S; Teramura M; Hoshino S; Motoji T; Oshimi K; Mizoguchi H
    Br J Haematol; 1993 Apr; 83(4):539-44. PubMed ID: 7686030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of apoptosis-related genes from death receptor pathway in chronic myeloproliferative diseases.
    Tognon R; Gasparotto EP; Leroy JM; Oliveira GL; Neves RP; Carrara Rde C; Kashima S; Covas DT; Santana M; Souto EX; Zanichelli MA; Velano CE; Simões BP; Alberto FL; Miyashiro K; de Souza AM; Amarante-Mendes GP; de Castro FA
    J Clin Pathol; 2011 Jan; 64(1):75-82. PubMed ID: 21045235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mast cells in human digestive tube in normal and pathological conditions.
    Rizzi A; Crivellato E; Benagiano V; Ribatti D
    Immunol Lett; 2016 Sep; 177():16-21. PubMed ID: 27393495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-33 synergistically enhances immune complex-induced tumor necrosis factor alpha and interleukin-8 production in cultured human synovium-derived mast cells.
    Kashiwakura J; Yanagisawa M; Lee H; Okamura Y; Sasaki-Sakamoto T; Saito S; Tokuhashi Y; Ra C; Okayama Y
    Int Arch Allergy Immunol; 2013; 161 Suppl 2():32-6. PubMed ID: 23711851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of prostaglandin D2 through the p38 MAPK pathway is responsible for the antipruritic activity of sertaconazole nitrate.
    Kaur S; Sur R; Liebel FT; Southall MD
    J Invest Dermatol; 2010 Oct; 130(10):2448-56. PubMed ID: 20505747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.